Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-338 (Acotiamide) in Functional Dyspepsia
NCT00458328Phase 2Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Apr 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acotiamide in functional dyspepsia (FD), sponsored by Zeria Pharmaceutical Co., Ltd.. Started Apr 2007; status: completed.
02
Drugs
acotiamide
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT00458328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458328.